We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER
JAMA Cardiol 2023 Feb 22;[EPub Ahead of Print], JH Butt, KF Docherty, BL Claggett, AS Desai, M Petersson, AM Langkilde, RA de Boer, AF Hernandez, SE Inzucchi, MN Kosiborod, L Køber, CSP Lam, FA Martinez, P Ponikowski, MS Sabatine, SJ Shah, M Vaduganathan, PS Jhund, SD Solomon, JJV McMurray